<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-CKOCW4R2/108b0a4f-ec15-435c-8c60-08ce98f2cb08/PDF"><dcterms:extent>2221 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-CKOCW4R2/f1164256-c7f0-45f2-870c-547e1927c7b4/TEXT"><dcterms:extent>54 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-CKOCW4R2"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>1998</dcterms:issued><dc:creator>Osmak, Maja</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:32</dc:format><dc:format xml:lang="sl">str. 19-33</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID:7823065</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-CKOCW4R2</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">Antineoplastic agents</dc:subject><dc:subject xml:lang="sl">citostatiki</dc:subject><dc:subject xml:lang="sl">Dna repair</dc:subject><dc:subject xml:lang="sl">Dna topoisomerase</dc:subject><dc:subject xml:lang="sl">Drug resistance</dc:subject><dc:subject xml:lang="sl">Drug resistance, neoplasm</dc:subject><dc:subject xml:lang="sl">Gene amplification</dc:subject><dc:subject xml:lang="sl">Glutathione</dc:subject><dc:subject xml:lang="sl">Glutathione peroxidase</dc:subject><dc:subject xml:lang="sl">Glutathione transferases</dc:subject><dc:subject xml:lang="sl">Metallothionein</dc:subject><dc:subject xml:lang="sl">molekularna biologija</dc:subject><dc:subject xml:lang="sl">odpornost</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">tumorske celice</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Molecular alterations induced in drug-resistant cells|</dc:title><dc:description xml:lang="sl">The major obstacle to the ultimate success in cancer therapy is the ability oftumor cells to develop resistance to anticancer drugs. Several molecular mechanisms have been suggested to be involved in drugresistance: a) decrease in the intracellular drug accumulation (increased activity of membrane transporters such as P-glycoprotein or multidrug-resistance-associated protein), b) changes in intracellular detoxification system (increased concentrations of glutathione or metallothioneins, or increased activity of related enzymed), c) alteration in nuclear enzymes (enhanced DNA repair and/orbetter tolerance of DNA damage, decreased acitivty of topoisomerases), d) altered expression of oncogenes (inducing increased level of protective molecules in cells or the inhibition of apoptosis). Drug resistance is a multifactorial phenomenon. The complexity of molecular alterations in drug-resistant cells is and will stay the main problem for the successful treatment of cancer</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-CKOCW4R2"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-CKOCW4R2" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-CKOCW4R2/108b0a4f-ec15-435c-8c60-08ce98f2cb08/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-CKOCW4R2/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-CKOCW4R2" /></ore:Aggregation></rdf:RDF>